FDA.reportPublic FDA data

deflazacort 6 MG Oral Tablet

RxCUI
153098
RxNorm name
deflazacort 6 MG Oral Tablet
Display name
deflazacort 6 MG Oral Tablet
Full name
deflazacort 6 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DeflazacortDEFLAZACORTDoppel Farmaceutici S.r.l.34a03eb7-74f5-4471-e063-6394a90aca632026-08-27Warnings, Adverse reactionsExact identifier
rxcui: 153098
JAYTHARIDEFLAZACORTDoppel Farmaceutici S.r.l.3542a1e3-acfd-6b9a-e063-6394a90a94662026-08-27Warnings, Adverse reactionsExact identifier
rxcui: 153098
DeflazacortDEFLAZACORTZydus Pharmaceuticals (USA) Inc.f99fde7c-91ac-4d67-bd76-2b18a1d31f7d2026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 153098
JAYTHARIDEFLAZACORTZydus Pharmaceuticals (USA) Inc.ced839ee-1131-45c6-9e38-cc81d85daf1c2026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 153098
DeflazacortDEFLAZACORTUpsher-Smith Laboratories, LLC40818600-3ff0-4c9c-8e31-2001425a7dc92026-07-06Warnings, Adverse reactionsExact identifier
rxcui: 153098
DeflazacortDEFLAZACORTAurobindo Pharma Limited77d7525d-89c9-4fde-a6a8-0a463fd6cfeb2026-06-01Warnings, Adverse reactionsExact identifier
rxcui: 153098
DeflazacortDEFLAZACORTAvKARE459b75a2-3242-3048-e063-6394a90ab8822025-12-10Warnings, Adverse reactionsExact identifier
rxcui: 153098
DeflazacortDEFLAZACORTSun Pharmaceutical Industries, Inc.fb5350d5-ead1-41f4-8b25-0da0bd7fcffe2025-12-09Warnings, Adverse reactionsExact identifier
rxcui: 153098
EMFLAZADEFLAZACORTPTC Therapeutics, Inc.31b347d2-f156-4055-9d8f-7cf0df4202962025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 153098
KYMBEEDEFLAZACORTUpsher-Smith Laboratories, LLC89365f9f-a7ae-40d3-aecc-e4add75d21c22025-07-17Warnings, Adverse reactionsExact identifier
rxcui: 153098
DeflazacortDEFLAZACORTAmneal Pharmaceuticals NY LLC18518568-a40b-41cb-91ce-44fbb55579712025-06-16Warnings, Adverse reactionsExact identifier
rxcui: 153098

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 9 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
31b347d2-f156-4055-9d8f-7cf0df420296deflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]221These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 201720251113
40818600-3ff0-4c9c-8e31-2001425a7dc9deflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]26These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720250501
18518568-a40b-41cb-91ce-44fbb5557971deflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]23These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS . DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720250616
f99fde7c-91ac-4d67-bd76-2b18a1d31f7ddeflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS DEFLAZACORT tablets, for oral use Initial U.S. Approval:201720251217
fb5350d5-ead1-41f4-8b25-0da0bd7fcffedeflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720251209
ced839ee-1131-45c6-9e38-cc81d85daf1cdeflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI JAYTHARI (deflazacort) tablets, for oral use Initial U.S. Approval:201720250519
77d7525d-89c9-4fde-a6a8-0a463fd6cfebdeflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720240613
459b75a2-3242-3048-e063-6394a90ab882deflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]21DEFLAZACORT tablets, for oral use These highlights do not include all the information needed to use DEFLAZACORT TABELTS safely and effectively. See full prescribing information for DEFLAZACORT TABELTS Initial U.S. Approval: 201720251210
89365f9f-a7ae-40d3-aecc-e4add75d21c2deflazacort 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [SCD]21HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYMBEE safely and effectively. See full prescribing information for KYMBEE. KYMBEE TM (deflazacort) tablets, for oral use Initial U.S. Approval: 201720250717